Product Overview
Selank – Research‑Grade Tuftsin‑Derived Peptide for Neuroimmune and Behavioural Pathway Investigation.
Synonyms: Thr‑Lys‑Pro‑Arg‑Pro‑Gly‑Pro; Tuftsin analogue
CAS Number: 129954‑34‑3
Sequence: Thr‑Lys‑Pro‑Arg‑Pro‑Gly‑Pro
Molecular Weight: Approx. 861.0 Da
Form: Lyophilised powder
Purity: ≥98% (HPLC)
Use: For laboratory research only. Not for human or veterinary use.
Overview:
Selank is a synthetic heptapeptide derived from the naturally occurring immunomodulatory peptide Tuftsin. It is widely utilised in research exploring interactions between the central nervous system and immune pathways.
Current scientific investigations focus on its potential involvement in GABAergic signalling, cytokine expression, and stress‑related neurochemical processes.
Its structural stability and ability to cross the blood–brain barrier in non‑human models make it suitable for controlled in vitro and in vivo research examining neuroimmune and behavioural regulation.
Mechanistic Insights:
Preclinical studies have examined Selank in relation to several biological processes:
• GABAergic Modulation – Investigated for its interaction with GABA receptor subunits and its potential to influence inhibitory neurotransmission.
• Cytokine Regulation – Studied for its effects on pro‑ and anti‑inflammatory cytokine expression in immune‑related models.
• Monoamine Activity – Explored for possible modulation of serotonin and dopamine turnover in non‑human systems.
• Stress‑Response Pathways – Evaluated for its impact on behavioural and biochemical responses to chronic stress in research subjects.
These findings are derived from published scientific literature and do not indicate or imply any clinical, therapeutic, or physiological effects in humans.
Research Context:
Selank is used exclusively within controlled laboratory environments for:
• Neuroimmune signalling and cytokine expression studies
• Behavioural and anxiolytic‑related research in non‑human models
• Investigations into GABAergic receptor interactions
• Comparative studies involving neuropeptides or benzodiazepine‑related compounds
This material is not intended for therapeutic, diagnostic, or clinical use.
Packaging & Storage:
- Supplied as a sterile‑filtered, lyophilised peptide
• Store at –20°C, protected from light and moisture
• Reconstitute under sterile laboratory conditions using bacteriostatic water or a suitable research‑grade diluent
• Store reconstituted solutions at 2–8°C and use within an appropriate timeframe according to institutional guidelines
Additional solubility data and technical documentation are available to qualified research institutions upon request.
Compliance Notice:
This product is intended solely for laboratory research purposes.
It is not approved for human or veterinary administration and must not be incorporated into food, cosmetics, pharmaceuticals, or any product intended for biological exposure.
All information provided is for educational and scientific reference only. Researchers are responsible for ensuring compliance with all applicable regulations, institutional policies, and safety standards.
